Demo · synthetic data

Company

Kinship Health

Back to the book

Clinical documentation that writes the note the trust will actually file.

LondonVertical · Healthhealthy

3.08x

ARR

€4.4m

+5.7% MoM · +144.4% since Nov 25

Net burn

€550k / mo

Implied cash €7.7m

Runway

14 mo

Outside the nine-month line

People

39

NRR 118% · GM 74%

watch

One NHS procurement slipped a quarter

The trust is still in the pilot. Pipeline coverage for the year holds, but Q4 bookings are now the number that matters, not the demo count.

Suggested action. Ask for a named-buyer forecast at the November board. If two trusts move to ‘next fiscal’, reopen the 2027 plan before we talk about the reserve.

ARR

€m, monthly

Net burn

€m per month

Monitoring note

Clinicians finish the note. That sounds small and it is the whole company. Coding quality is ahead of the last two health deals we passed. The sales cycle is the constraint, and it is a public-sector sales cycle, which we knew.

Entry

Date
14 Feb 2024
Round
Seed
Ownership
16.8%
Cost
€13m
Fair value
€40m
Reserve left
€4m
Partner
Tomasz Rehn
Rights
Board seat